Sweden · Delayed Price · Currency is SEK MedCap AB Statistics
Total Valuation
MedCap AB has a market cap or net worth of SEK 6.88 billion. The enterprise value is 6.96 billion.
| Market Cap | 6.88B |
| Enterprise Value | 6.96B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedCap AB has 15.02 million shares outstanding. The number of shares has increased by 0.78% in one year.
| Current Share Class | 15.02M |
| Shares Outstanding | 15.02M |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 37.79% |
| Float | 11.87M |
Valuation Ratios
The trailing PE ratio is 30.53 and the forward PE ratio is 19.51.
| PE Ratio | 30.53 |
| Forward PE | 19.51 |
| PS Ratio | 3.16 |
| PB Ratio | 4.50 |
| P/TBV Ratio | 23.04 |
| P/FCF Ratio | 21.88 |
| P/OCF Ratio | 20.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.50, with an EV/FCF ratio of 22.15.
| EV / Earnings | 30.92 |
| EV / Sales | 3.20 |
| EV / EBITDA | 15.50 |
| EV / EBIT | 22.83 |
| EV / FCF | 22.15 |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.31.
| Current Ratio | 2.10 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 1.06 |
| Debt / FCF | 1.52 |
| Interest Coverage | 7.57 |
Financial Efficiency
Return on equity (ROE) is 15.91% and return on invested capital (ROIC) is 14.71%.
| Return on Equity (ROE) | 15.91% |
| Return on Assets (ROA) | 8.06% |
| Return on Invested Capital (ROIC) | 14.71% |
| Return on Capital Employed (ROCE) | 14.01% |
| Weighted Average Cost of Capital (WACC) | 6.81% |
| Revenue Per Employee | 3.42M |
| Profits Per Employee | 353,532 |
| Employee Count | 637 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 3.04 |
Taxes
In the past 12 months, MedCap AB has paid 68.50 million in taxes.
| Income Tax | 68.50M |
| Effective Tax Rate | 23.27% |
Stock Price Statistics
The stock price has increased by +4.77% in the last 52 weeks. The beta is 0.47, so MedCap AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +4.77% |
| 50-Day Moving Average | 481.35 |
| 200-Day Moving Average | 547.09 |
| Relative Strength Index (RSI) | 43.05 |
| Average Volume (20 Days) | 15,211 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedCap AB had revenue of SEK 2.18 billion and earned 225.20 million in profits. Earnings per share was 15.00.
| Revenue | 2.18B |
| Gross Profit | 1.29B |
| Operating Income | 305.10M |
| Pretax Income | 294.40M |
| Net Income | 225.20M |
| EBITDA | 405.40M |
| EBIT | 305.10M |
| Earnings Per Share (EPS) | 15.00 |
Balance Sheet
The company has 394.40 million in cash and 478.10 million in debt, with a net cash position of -83.70 million or -5.57 per share.
| Cash & Cash Equivalents | 394.40M |
| Total Debt | 478.10M |
| Net Cash | -83.70M |
| Net Cash Per Share | -5.57 |
| Equity (Book Value) | 1.53B |
| Book Value Per Share | 101.58 |
| Working Capital | 572.70M |
Cash Flow
In the last 12 months, operating cash flow was 339.00 million and capital expenditures -24.60 million, giving a free cash flow of 314.40 million.
| Operating Cash Flow | 339.00M |
| Capital Expenditures | -24.60M |
| Depreciation & Amortization | 100.30M |
| Net Borrowing | 64.80M |
| Free Cash Flow | 314.40M |
| FCF Per Share | 20.93 |
Margins
Gross margin is 59.19%, with operating and profit margins of 14.02% and 10.35%.
| Gross Margin | 59.19% |
| Operating Margin | 14.02% |
| Pretax Margin | 13.53% |
| Profit Margin | 10.35% |
| EBITDA Margin | 18.63% |
| EBIT Margin | 14.02% |
| FCF Margin | 14.45% |
Dividends & Yields
MedCap AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | -0.78% |
| Earnings Yield | 3.27% |
| FCF Yield | 4.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |